Scientifically, it's a cyclic heptapeptide with high affinity for MC4R (EC50 ~1 nM), making it highly specific for central arousal pathways.[4] It boosts desire, arousal, and lubrication through neurological activation, offering benefits like increased motivation and physical readinessdistinct from vascular drugs like sildenafil.[1][4][5] Studies show it improves HSDD symptoms, with 51% of women reporting significant desire boosts in phase 3 trials.[1] Biohacker Ben Greenfield has noted: "PT-141 enhances response efficiently, making it a go-to for biohacking intimacy without side effects of traditional meds."[17] For experts, its brain-targeted action avoids cardiovascular risks, positioning it as a versatile tool for HSDD, with preclinical data showing sustained dopamine release
Centrifuge anticoagulant-treated blood at 1,000 g for 10 min at 4C
Meanwhile, they defined dementia as vascular and nonvascular dementias and Alzheimers disease
10.1016/j.mayocp.2019.01.001 Mayo Clin
All purchases confirm research-only intent